AJMC Staff

President-elect Joe Biden will call for 100 days of mask-wearing on inauguration day; HHS announces maternal morbidity action plan; Pelosi, McConnell in virus relief talks.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The United States reports record numbers of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19); the CDC updates its quarantine recommendations; Moderna will soon start testing its COVID-19 vaccine in children.

Use of selexipag in patients with connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) resulted in outcomes similar to those seen in patients with idiopathic PAH, despite the traditionally poorer prognosis of CTD-PAH.

Avazo-Healthcare warned by the FDA about its coronavirus disease 2019 (COVID-19) testing kits; Pfizer, BioNTech get first COVID-19 vaccine approval; risk for Guillan-Barré syndrome from flu vaccine deemed insignificant.

The first blood test to help diagnose Alzheimer disease is now for sale; AstraZeneca will sell the rights to its cholesterol drug Crestor for $320 million; Black children are disproportionately affected by severe syndrome linked with coronavirus disease 2019 (COVID-19).

Anthony Fauci, MD, warns of potential upticks in cases of coronavirus disease 2019 (COVID-19) after holiday travel; the United Kingdom is set to give the first approval to Pfizer, BioNTech’s COVID-19 vaccine candidate; health officials from South Carolina to offer free HIV testing.

Severe aplastic anemia used to have few options and mortality was high, but a new class of drugs offers some hope.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Operation Warp Speed officials said they plan to release 6.4 million vaccines against coronavirus disease 2019 (COVID-19) in the initial distribution; OxyContin manufacturer Purdue Pharma pleads guilty to role in opioid epidemic; spotlighting difficulty in employer testing for COVID-19.

CDC pushes for prioritized contact tracing; urban hospitals struggle to keep up with influx of rural patients; Texas and Louisiana can cut Medicaid funding to Planned Parenthood.

AstraZeneca announced that its vaccine against coronavirus disease 2019 (COVID-19) could be up to 90% effective; FDA grants emergency use authorization (EUA) for antibody cocktail used against COVID-19; spotlighting shortage of specialists to operate ventilators.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

AstraZeneca data show the company's coronavirus disease 2019 vaccine had promising results in older adults; nurses implore the public to take virus safety precautions; a new report highlights employees on food stamps, Medicaid.

Final data released overnight show Pfizer’s coronavirus disease 2019 (COVID-19) vaccine is 95% effective; the first at-home COVID-19 test receives a regulatory go-ahead; Amazon launches its first digital drugstore.

The FDA will move rapidly to clear Pfizer's and Moderna’s coronavirus disease 2019 vaccines for emergency use; approval of Alkermes' ALKS 3831 is pending; California's governor is tightening restrictions for 94% of the state’s residents.

Nearly 20 million people could be vaccinated against coronavirus disease 2019 in December; FDA approves a companion diagnostic for triple-negative breast cancer (TNBC); Anthony Fauci, MD, urges continued mask wearing as vaccines become available.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A look into the US cities hardest hit by cases of coronavirus disease 2019 (COVID-19); Anthony Fauci, MD, urges Americans to double down on health precautions amid COVID-19 surges; a study spotlights risk of high health care costs among the insured.

The Gates Foundation will add another $70 million of funding for vaccines and treatments against coronavirus disease 2019 (COVID-19); nursing homes see rising COVID-19 cases; finding health coverage for workers laid off due to the pandemic.

The US may have inadequate testing for coronavirus disease 2019 (COVID-19); potentially 80% of new COVID-19 cases are linked to indoor venues; protection against measles and mumps is suboptimal among cancer patients.

The liquid serum assay was cleared for use as a companion diagnostic for olaparib to identify patients with BRCA1/2- and/or ATM-mutated metastatic castration-resistant prostate cancer.

FDA approves a coronavirus disease 2019 (COVID-19) antibody treatment; North Dakota braces hospitals for surging cases; fruit consumption among children is low.

Medicare Part B outpatient premiums will increase in 2021; nursing homes report rises in coronavirus disease 2019 (COVID-19) cases; advisory panel votes down Biogen's Alzheimer disease drug.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Although the fate of the Senate remains undecided, President-elect Joe Biden’s Democratic win spells major changes for both the handling of the coronavirus disease 2019 pandemic and health care in the United States.

Understanding these genetic variants discovered through sequencing efforts is key to further progress in clinical genetics.